Tag: Prescription Drugs
ADHD Meds May Help Control Opioid Use Disorder in Pregnancy
Additional benefits include increased buprenorphine initiation, decreased methadone initiation, and improved buprenorphine retention
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
AA genotype linked to reduced severity, but not occurrence, of TD; no association seen for rs210133 with TD occurrence, severity
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAF V600E mutation
Timing of Metformin Important in Metformin-Treated Type 2 Diabetes
Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response
Improved Outcomes Seen With Ibrutinib in Chronic Lymphocytic Leukemia
Time to next treatment was improved for first-line ibrutinib versus chemoimmunotherapy in match-adjusted analyses
Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy
Findings seen in patients with no preexisting history of stroke or cardiovascular disease in subgroup analyses
ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma
Complete responses seen in 38 percent of patients, all with non-GCB DLBCL, high-grade B-cell lymphoma with rearrangements of MYC and BCL2 or BCL6
Reteplase Superior to Alteplase Within 4.5 Hours of Ischemic Stroke
Reteplase more likely to result in excellent functional outcome than alteplase for ischemic stroke within 4.5 hours of symptom onset
FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors
Approval is for both TKI-naive and TKI-pretreated patients across solid tumor types
Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor Antagonists
Risk for developing DLB was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI